You are here

CureVac

CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South

CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South

Medical Marketing and Media

Flag link:

Orbital shows 2023’s venture funding scene is far from stratospheric

Orbital shows 2023’s venture funding scene is far from stratospheric

EP Vantage

venture capital

Hasten Biopharmaceutic

Orbital Therapeutics

Sana Biotechnology

Suzhou Abogen Biosciences

TORL BioTherapeutics

Flag link:

GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine

GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine

Clinical Trials Arena

Flag link:

After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults

After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults

Fierce Biotech

clinical trials

Flag link:

CureVac's 'half-baked' COVID-flu data release questioned by analysts, but shares still rally 17%

CureVac's 'half-baked' COVID-flu data release questioned by analysts, but shares still rally 17%

Fierce Biotech

clinical trials

Flag link:

CureVac rethinks lead cancer program after posting PD-1 data, limiting future studies to mRNA vaccine combos

CureVac rethinks lead cancer program after posting PD-1 data, limiting future studies to mRNA vaccine combos

Fierce Biotech

Flag link:

CureVac begins Phase I Omicron-targeting Covid-19 vaccine trial

CureVac begins Phase I Omicron-targeting Covid-19 vaccine trial

Clinical Trials Arena

clinical trials

Flag link:

Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits

Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits

BioSpace

Flag link:

Pfizer, BioNTech rebuff CureVac's 'groundless' patent infringement claims against COVID-19 shot Comirnaty

Pfizer, BioNTech rebuff CureVac's 'groundless' patent infringement claims against COVID-19 shot Comirnaty

Fierce Pharma

Flag link:

After its own vaccine flop, CureVac sues Pfizer partner BioNTech for patent infringement

After its own vaccine flop, CureVac sues Pfizer partner BioNTech for patent infringement

Fierce Pharma

Flag link:

CureVac increases focus on cancer vaccine development

CureVac increases focus on cancer vaccine development

Biopharma Reporter

Flag link:

With failed COVID shot still dragging on earnings, CureVac tries to turn page to next-gen mRNA tech

With failed COVID shot still dragging on earnings, CureVac tries to turn page to next-gen mRNA tech

Fierce Biotech

Flag link:

GlaxoSmithKline, CureVac and BioNTech clinch German pandemic preparedness contracts

GlaxoSmithKline, CureVac and BioNTech clinch German pandemic preparedness contracts

Fierce Pharma

Flag link:

CureVac and GSK try again with COVID-19 vaccine

CureVac and GSK try again with COVID-19 vaccine

Pharmaforum

Flag link:

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report

Fierce Pharma

Flag link:

CureVac Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candidate, CV2CoV, Demonstrating Comparable Antibody Levels to Licensed mRNA Vaccine

CureVac Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candidate, CV2CoV, Demonstrating Comparable Antibody Levels to Licensed mRNA Vaccine

Yahoo Finance

Flag link:

End-of-Year Restructuring Means Layoffs for These Companies

End-of-Year Restructuring Means Layoffs for These Companies

BioSpace

Rigel Pharmaceuticals

Esperion Therapeutics

Acorda Therapeutics

Ziopharm Oncology

Flag link:

Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report

Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report

Endpoints

drug manufacturing

Flag link:

Pages